Bank of Montreal
XFOR icon

Bank of Montreal’s X4 Pharmaceuticals XFOR Stock Holding History

Bank of Montreal’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16
Closed -$5K – 4975
2021
Q1 		$5K Sell
16
-68
-81% -$17.9K ﹤0.01% 4673
2020
Q4 		$19K Buy
84
+59
+236% +$11.6K ﹤0.01% 4444
2020
Q3 		$5K Sell
25
-18
-42% -$4.32K ﹤0.01% 4455
2020
Q2 		$10K Buy
+43
New +$11.8K ﹤0.01% 4186
2020
Q1 		– Sell
-50
Closed -$16K – 4785
2019
Q4 		$16K Buy
50
+15
+43% +$5.38K ﹤0.01% 4424
2019
Q3 		$13K Buy
35
+15
+75% +$5.94K ﹤0.01% 4329
2019
Q2 		$9K Buy
+20
New +$10.2K ﹤0.01% 4568
2019
Q1 		– Hold
0
– – – 4796
2018
Q4 		– Hold
0
– – – 4881
2018
Q3 		– Hold
0
– – – 4919
2018
Q2 		– Hold
0
– – – 4895

Other funds holding XFOR

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Bank of Montreal's XFOR Position: Q2 2021 in Review

Bank of Montreal sold out of X4 Pharmaceuticals (XFOR) in Q2 2021, closing a stake of 16 shares — an estimated $5K sold.

Bank of Montreal first reported a position in XFOR in Q2 2019 and held it in 7 quarters. The position peaked at $19K in Q4 2020. 62 funds tracked by Wall St. Rank hold XFOR as of Q2 2021.

  • Bank of Montreal reported no remaining X4 Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 16 X4 Pharmaceuticals shares in Q2 2021, an estimated $5K.
  • Bank of Montreal first reported a position in X4 Pharmaceuticals in Q2 2019 and held it in 7 quarters.
  • Bank of Montreal's X4 Pharmaceuticals position peaked at $19K in Q4 2020.
  • 62 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.